Fed Regist. 2004 Jan 6;69(3):819-44.
This interim final rule with comment period implements provisions of the Medicare Prescription Drug, Improvement, and Modernization Act (DIMA) of 2003 that affect the Medicare outpatient prospective payment system (OPPS) that become effective January 1, 2004. Sections 303 and 621 of the DIMA include provisions that alter the methods for drug payment in hospital outpatient departments, some of which become effective January 1, 2004. These provisions affect the methodology for paying for pass-through and non-pass-through drugs under the OPPS. Further, the new law includes a requirement that all brachytherapy sources be paid separately. Section 411 of the DIMA reinstates the hold-harmless protection for small rural hospitals with fewer than 100 beds and extends that protection to sole community hospitals in rural areas.
本带有意见征求期的暂行最终规则实施了2003年《医疗保险处方药、改进与现代化法案》（DIMA）中影响医疗保险门诊前瞻性支付系统（OPPS）的条款，这些条款于2004年1月1日生效。DIMA的第303条和第621条包含改变医院门诊部门药品支付方法的条款，其中一些条款于2004年1月1日生效。这些条款影响了OPPS下支付直通和非直通药品的方法。此外，新法律要求所有近距离放射治疗源单独支付。DIMA的第411条恢复了对床位少于100张的小型农村医院的无害保护，并将该保护扩展到农村地区的唯一社区医院。
